GSS 0.00% 67.5¢ genetic signatures limited

Ann: Update to major customer contract announcement, page-7

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 178 Posts.
    lightbulb Created with Sketch. 28
    Yes it needs FDA approval . GSS have limited approval for their Enteric product in the US , it can be used by around 8,000 certified labs . So far there are labs trialing and assessing the product and one major lab has opted to use the product and has placed repeat orders . Other products are going though the validation process to aquire FDA approval . I would hope once the FDA fully appreciates the tech they will pass future products without major scrutiny but we are talking about the FDA here . I think the EU and Australian markets are the short term goals it seems the EU are more willing to accept new / better tech . I do think as I have stated in previous posts once GSS obtains more EU /US approvals one of the big players will try to aquire GSS . This tech is the future in pathology industry and the major players won’t want to be left behind .
 
watchlist Created with Sketch. Add GSS (ASX) to my watchlist
(20min delay)
Last
67.5¢
Change
0.000(0.00%)
Mkt cap ! $155.4M
Open High Low Value Volume
70.0¢ 70.0¢ 67.5¢ $8.472K 12.18K

Buyers (Bids)

No. Vol. Price($)
2 29814 67.5¢
 

Sellers (Offers)

Price($) Vol. No.
69.5¢ 900 1
View Market Depth
Last trade - 11.38am 03/12/2024 (20 minute delay) ?
GSS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.